Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies

This study has been completed.
Information provided by (Responsible Party):
Millennium Pharmaceuticals, Inc. Identifier:
First received: January 26, 2009
Last updated: June 23, 2014
Last verified: June 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2012
  Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)